Follow the 큐리언트 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 103 public disclosures. Market capitalisation: €851.4bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is openly available.
101
Insider Decl.
n/a
Thresholds
€42,602
32 ops.
Buy Volume
n/a
5 ops.
Sell Volume
16Σ signal
Buys €42,602n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,463 of 29,156 companies
16.8
score / 100
Value
25
Quality
9
FCF yld-3.8%
Earn yld-3.5%
EV/EBITDA·
ROE-102%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
큐리언트 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.